Latest information on COVID-19
Support teaching, research, and patient care.
In my academic and scholarship endeavors, I continue to be guided by a commitment to patient care and a desire to teach, learn, and conduct research in a multifaceted and multidisciplinary field. Cardiac electrophysiology is a dynamic and innovative field, pushing at the boundaries of science and medicine; new research findings are quickly translated to the clinical setting. In this environment of active research endeavors and strong clinical growth, I have sought to bring innovative approaches, both clinical and translational, to the treatment of cardiac arrhythmias.Clinical Interests My clinical interests include management of complex arrhythmias through the use of medications and/or ablation technologies for all types of tachycardias, including atrial fibrillation and ventricular tachycardia; cardiac device placements such as biventricular pacemakers and defibrillators; and implantation of left atrial appendage closure devices for stroke prevention in patients with atrial fibrillation. I have a strong focus on complex ablations in patients with life-threatening arrhythmias such as ventricular tachycardia/fibrillation and in patients with complex congenital heart abnormalities. Care Philosophy Cardiology and electrophysiology are highly technical fields utilizing the latest and most advanced technology to deliver outstanding care. However, at the end of the day, I believe that the best care for my patients involves listening to them, informing them about their illness, involving them in their care, and always doing what is in their best interests. Volunteer Activities I came here as a refugee from war and have been fortunate to gain the experiences that I have had, so that I can give back to the community. I have worked in homeless shelters, taught GED and ESL, vaccinated at-risk youths from hepatitis B, and worked to treat and prevent HIV/AIDS in impoverished communities.
The long-term goals of my translational research are to evaluate novel radiofrequency (RF) ablation strategies, catheter designs to improve procedural efficacy and safety outcomes, and molecular targets to enhance RF ablation of atrial fibrillation and ventricular tachycardia. We have translational and clinical studies on multiple ablation catheter designs as well as ablation strategies to improve safety and maximize RF delivery during ablation for atrial fibrillation and ventricular tachycardia. We have both in vivo and ex vivo animal models (small and large animal) of atrial and ventricular arrhythmias.<br/><br/>At the translational level, our ablation biophysics studies include utilizing various nanomaterials to help facilitate ablation as well as designing specialized catheters to improve safety and efficacy of ablation. We are studying specific variations in catheter design to improve ablation; testing delivery methods of facilitating agents; optimizing biophysical parameters; determining the precise RF electromagnetic field to minimize collateral damage; and studying magnetic driven facilitating agents.<br/> <br/>At the clinical level, my research has focused on the application of biophysical principles to AF and VT ablation outcomes, in addition to research related to adult congenital heart disease. Projects include a multicenter consortium on the use of EP studies in risk stratification of sudden death for Tetralogy of Fallot (ToF) patients undergoing pulmonary valve replacement; perioperative EP studies and VT ablation in ToF patients; outcomes in multicenter cohorts of ACHD patients undergoing AF and VT ablations; and outcomes in ACHD subpopulations undergoing EP procedures, such as those with bicuspid aortic valves, right atrial myopathies, and others.